在2025年的白血病进展之旅,通过MD安德森白血病研究镜头观看
Hagop M Kantarjian1, Gautam Borthakur1, Naval Daver1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer
|October 23, 2025
概括
向疗法改变了白血病的治疗方法,改善了许多患者的治疗结果,并减少了许多患者对化疗的依赖. 对高风险白血病亚型需要进一步的进展.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 在过去的20年里,白血病治疗取得了重大进展.
- 向疗法彻底改变了白血病管理,提高了生存率.
- 由于新的治疗方法,许多白血病类型的化疗强度已经减少.
研究的目的:
- 审查急性和慢性白血病治疗的最新进展.
- 突出针对性治疗对白血病结局的影响.
- 确定需要进一步研究白血病治疗的领域.
主要方法:
- 关于白血病预后,监测和治疗的最新科学文献的综述.
- 针对性疗法的影响分析,包括抗体和小分子抑制剂.
- 基于风险分层和治疗反应的白血病类型的分类.
主要成果:
- 针对性疗法,如布利纳图莫马布,伊诺图祖马布,BCR::ABL1 TKIs,BTK 抑制剂和venetoclax,已经大大改变了治疗环境.
- 在许多白血病类型的化疗强度降低的情况下,观察到改善的生存结果.
- 如慢性淋巴细胞白血病,年轻急性淋巴细胞白血病和费城染色体阳性急性淋巴细胞白血病等白血病类型现在被认为是有利的.
结论:
- 在过去的二十年中,白血病治疗的显著进展使得治疗结果得到改善.
- 向疗法在许多白血病亚型中提高了生存率并减少了化疗依赖性.
- 进一步的研究对于改善TP53突变,MECOM重组和治疗的二次AML等不良风险组的结果至关重要.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


